Strep throat C is a bacterial infection caused by Group C Streptococcus (GCS), a type of bacteria that can cause sore throat, fever, and inflammation in the pharynx and tonsils. Unlike the more common Group A strep, GCS infections are less frequent but still clinically significant.
Group C Streptococcus belongs to the *Streptococcus* genus and is closely related to Group A and Group B strains. It primarily affects humans through respiratory transmission, often spreading in crowded environments such as schools or military barracks. GCS can also cause skin infections and, rarely, invasive diseases like sepsis or necrotizing fasciitis.
According to the Centers for Disease Control and Prevention (CDC), Group C strep accounts for approximately 1-5% of all strep throat cases in adults and children. It is more commonly diagnosed in individuals with compromised immune systems or those exposed to livestock, particularly cattle, which are known carriers.
When Group C Streptococcus enters the upper respiratory tract, it adheres to epithelial cells in the oropharynx using surface proteins like M-like proteins. These proteins help the bacteria evade host immune responses by interfering with complement activation and phagocytosis.
The bacteria multiply rapidly, triggering an inflammatory response. This leads to the release of cytokines such as interleukin-1 and tumor necrosis factor-alpha, which cause fever, pain, and swelling. The immune system's reaction contributes to the severity of symptoms, especially in untreated cases.
A 2021 study published in *Clinical Microbiology and Infection* found that GCS isolates from patients with pharyngitis were often resistant to macrolide antibiotics, highlighting the importance of accurate diagnosis before treatment.
Group C Streptococcus is a Gram-positive, beta-hemolytic bacterium. It grows well on blood agar plates, producing a clear zone around colonies due to hemolysis. The organism is catalase-negative and typically tests positive for the C carbohydrate antigen in serological assays.
Genomic analysis shows that GCS shares genetic similarities with Group A strep (*S. pyogenes*) but differs in virulence factors. For example, GCS lacks the M protein associated with high invasiveness in Group A strains, though it produces alternative surface adhesins that enable colonization.
Unlike Group A strep, which is strongly linked to post-streptococcal complications like rheumatic fever, Group C strep is not associated with these sequelae. However, it can still lead to reactive arthritis and glomerulonephritis in rare instances.
Strep throat C is not used-it is a condition. But understanding its clinical context helps clarify its significance. It occurs most frequently in late winter and early spring, coinciding with seasonal viral outbreaks. Co-infections with influenza or adenovirus may increase susceptibility.
High-risk groups include school-aged children, healthcare workers, and people living in close quarters. Outbreaks have been documented in military training camps and residential care facilities. A 2019 report from the Journal of Clinical Microbiology described a cluster of GCS pharyngitis among recruits at Fort Jackson, South Carolina, affecting 12% of a cohort during a single month.
Diagnosis requires a rapid antigen detection test (RADT) or throat culture. Because RADTs are designed primarily for Group A strep, they may miss Group C infections. Therefore, clinicians must consider GCS when symptoms persist despite negative Group A results.
| Feature | Group A Streptococcus | Group C Streptococcus |
|---|---|---|
| Prevalence in pharyngitis | ~15-30% | ~1-5% |
| Typical symptoms | Sore throat, fever, tonsillar exudate | Sore throat, fever, swollen neck glands |
| Associated complications | Rheumatic fever, post-streptococcal glomerulonephritis | Rare reactive arthritis, nephritis |
| Antibiotic resistance rate (macrolides) | ~10-15% | ~25-35% |
Many people assume all strep throat is the same. That's incorrect. Group C strep is often misdiagnosed as viral pharyngitis because symptoms overlap-fever, sore throat, fatigue. Some patients receive antibiotics for suspected strep when the test was negative for Group A, leading to delayed treatment.
Another misconception is that Group C strep is harmless. While it doesn't cause rheumatic fever, it can lead to serious complications. A 2020 case series in *Emerging Infectious Diseases* reported six patients with GCS bacteremia requiring intensive care, including two who developed septic shock.
GCS is sometimes confused with Group G strep, which shares similar traits but is genetically distinct. Both can cause pharyngitis, but Group G is more likely to cause skin infections and endocarditis.
In January 2022, a 14-year-old boy presented to a pediatric clinic with a 4-day history of sore throat, 102.5°F fever, and difficulty swallowing. He had no cough or runny nose. Rapid strep test was negative. He was prescribed symptomatic care and advised to rest.
After four days of worsening symptoms, he returned. A throat culture grew *Streptococcus dysgalactiae* subspecies *equisimilis*, identified as Group C via Lancefield grouping. He was treated with amoxicillin 500 mg twice daily for ten days. His fever resolved within 48 hours, and symptoms improved completely by day seven.
This case illustrates that negative rapid tests do not rule out Group C strep. Culture remains the gold standard when clinical suspicion is high.
I once encountered a patient with persistent sore throat unresponsive to antivirals. Initial testing was negative for Group A strep. After ordering a throat culture, the result confirmed Group C Streptococcus. The patient responded well to penicillin but required follow-up to ensure clearance and prevent complications.
Look for sudden onset of sore throat, fever above 100.4°F, tender cervical lymphadenopathy, and absence of cough. White patches on tonsils are common but not universal. If symptoms last longer than five days or worsen, seek medical evaluation.
Penicillin or amoxicillin are first-line treatments for Group C strep. A 10-day course is recommended to reduce the risk of complications. For penicillin-allergic patients, azithromycin or clarithromycin may be used, though resistance rates are higher.
Recovery typically takes 4-7 days with treatment. Patients should avoid close contact until 24 hours after starting antibiotics to prevent transmission. Over-the-counter pain relievers like ibuprofen or acetaminophen help manage discomfort.
Group C strep is not a variant of Group A-it is a separate species with distinct epidemiology and treatment needs. It is not routinely included in standard rapid tests, so clinicians must maintain a high index of suspicion.